Status:
COMPLETED
Impact of a Nurse for Migraine Management: the IMPACT Project
Lead Sponsor:
Notre-Dame Hospital, Montreal, Quebec, Canada
Collaborating Sponsors:
Allergan
Conditions:
Migraine Without Aura
Migraine With Aura
Eligibility:
All Genders
18+ years
Brief Summary
Headache disorders are prevalent, disabling, under recognized, under diagnosed and under treated. Migraine has a prevalence of 10% in men and 25% in women in Canada. The treatment of migraine is based...
Detailed Description
STUDY DESIGN: The goal of this study is to compare two treatment approaches for migraineurs. The first approach will be based on the physician only and is limited to fixed appointments (control group...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Age 18 or more
- Diagnosis of migraine, chronic or episodic, at the first visit. We expect the majority of patients to suffer form frequent or chronic migraine.
- Consent to participate in the CHUM Migraine Clinic IMPACT project.
- For future post-hoc analysis, groups will be stratified according to baseline headache frequency (all severity included), assessed retrospectively at the first visit:
- \<6 headache days per month,
- 6 to 14 headache days per month
- 15 or more headache days per month
- EXCLUSION CRITERIA:
- Patients whom first headache diagnosis is not migraine (for example post-traumatic headache, cluster headache, trigeminal neuralgia, facial pain).
- Women with ongoing or planned pregnancy.
- Patient with an active psychiatric condition (needing hospitalisation or psychosis).
- Patient with mental retardation impairing assessment or follow-up.
- Patient with an active medical condition which may lead to frequent hospitalisations (eg active cancer, organ graft, hemodialysis etc). This will be determined and detailed by the evaluating physician.
- Active drug addiction or alcoholism.
- Active follow-up at a pain clinic.
- Patient speaking a language other than french and incapable to communicate in a reliable way.
Exclusion
Key Trial Info
Start Date :
February 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2015
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01804517
Start Date
February 1 2013
End Date
November 1 2015
Last Update
December 8 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Notre-Dame
Montreal, Quebec, Canada, H2L 4M1